To Present at World Leading Biotech Convention, 2015 BIO
Melbourne, May 18, 2015 AEST (ABN Newswire) - Rhinomed Ltd (
ASX:RNO) is pleased to announce that it has been accepted as a presenter at 2015 BIO, the world's leading biotech convention to be held in Philadelphia, June 15-18th.
KEY HIGHLIGHTS:
- Rhinomed accepted as a speaker at Global 2015 BIO Convention, Philadelphia, USA June 1518
- Company to showcase sleep and drug delivery platform advances
- Continuing on from successful recent distribution deals; reflects major push into global sleep and drug delivery markets
BIO is one of the premier global biotech conferences. It is attended by over 15,000 biotech and pharma leaders and provides an important opportunity for the company to expose its patented nasal platform technology to a broader range of potential partners and distributors.
With clear progress being made within its Sport and Sleep business units, the imminent start of the sleep apnoea trial featuring its new INPEAP technology, and progress in the drug delivery program, the business is receiving strong interest globally.
"BIO is a great opportunity to extend the conversations we are already having with a range of parties. It is also provides a great opportunity to introduce our platform to a much broader set of the world's leading biotech and pharma companies," commented CEO Michael Johnson.
"Rhinomed's internal nasal platform is rapidly gaining acceptance with thousands of users in both sport and sleep. With this growing level of acceptance, the platform provides a highly attractive, patented and derisked delivery platform for sleep and drug development companies and pharma," Johnson said.
The company will be travelling and exhibiting as part of the Victorian Government's delegation to 2015 BIO.
About Rhinomed Limited
Rhinomed Limited (ASX:RNO) is a Melbourne based technology firm with a focus on nasal, respiratory and breathing management technologies. The company is seeking to monetise applications of its technology portfolio in the Sport, Sleep, Wellbeing and Drug Delivery markets. For more information, go to www.rhinomed.global
Follow the Turbine on Twitter at @theturbinecom
Follow Mute Snoring on Twitter at @mutesnoring
| ||
|
